#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell lymphoma Acute graft versus host disease in liver Chronic myeloid leukaemia Ischaemic stroke Prader-Willi syndrome Sarcoma Extra-osseous Ewing's sarcoma recurrent B-cell lymphoma recurrent Gestational trophoblastic tumour Neuroendocrine tumour Gastrointestinal stromal tumour Ovarian cancer stage IV Mixed-type liposarcoma Round cell liposarcoma Gastrointestinal disorder More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic – Treatment MELAS syndrome – Treatment VEXAS syndrome – Trials in Disease Rett syndrome Hereditary motor and sensory neuropathy – Trials in Disease Glomerulonephritis membranous – Trials in Disease Cholangitis sclerosing – Treatment Ewing’s sarcoma – Diagnostics Skin angiosarcoma – Trials in Disease Synovial sarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PROMESTRIENE Tafluprost Poloxamer 407 Ivabradine Petosemtamab Mycophenolate Sodium Incb000928 Senicapoc Naloxegol Oxalate Vinblastine Sulfate Iodixanol Azathioprine Sodium Laurilsulfate Water For Injections Tuparstobart UDONITRECTAG Adrc GSK5784283 SAR443820 Bisoprolol More therapies…

    Learn about Your Condition

    Ulcerative keratitis Respiratory failure Pustular psoriasis Fallopian tube cancer stage IV Urea cycle disorder Tendon rupture Abortion threatened Mucopolysaccharidosis I Haemodynamic instability Cardiac failure chronic Guttate psoriasis Retinitis pigmentosa Cutaneous T-cell lymphoma Anogenital dysplasia Acute coronary syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2bd Boncpdidn Dm Syfqlh Mtvvopplqav Bm 1nng Mzshuiwrca 1mxfeh Fjpzvj

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Chemotherapy for Patients with Resected Pancreatic Cancer Using FOLFIRINOX and Drug Combination

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Fluorouracil
    • Gemcitabine
    • Irinotecan
    France

  • Study Comparing Rilvegostomig with Fluoropyrimidine and Trastuzumab Deruxtecan to Standard Treatment for Patients with HER2-positive Gastric Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • HER2 positive gastric cancer
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Fluorouracil
    Austria Belgium France Germany Hungary Italy +3

  • Study on the Effectiveness and Safety of Tagraxofusp and Venetoclax for Adults with Untreated Blastic Plasmacytoid Dendritic Cell Neoplasm

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • TAGRAXOFUSP
    • Venetoclax
    France

  • Study on the Safety and Effects of MK-3120 for Patients with Advanced Solid Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • SKB410
    France The Netherlands Poland Spain

  • Study on Detecting Tumor DNA in Blood for Patients with HR+, HER2 Low Metastatic Breast Cancer Using Trastuzumab Deruxtecan After Standard Therapy

    Recruiting

    2 1 1
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    France

  • Study on the Safety and Effectiveness of GSK5733584 with Dostarlimab and Carboplatin for Patients with Advanced Gynecological Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • GSK5733584
    • Dostarlimab
    • Bevacizumab
    Belgium Denmark Finland France Germany Greece +6

  • Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • BNT327
    • Carboplatin
    • Paclitaxel
    Belgium Bulgaria France Germany Hungary Italy +3

  • Study on MaaT033 and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-1/PD-L1 Blockade Due to Antibiotic Use

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    • Bevacizumab
    • Carboplatin
    France

  • Study Comparing Duvelisib with Gemcitabine or Bendamustine for Patients with Relapsed or Resistant T Cell Lymphoma Originating from T Follicular Helper Cells

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adult T-cell lymphoma/leukaemia refractory
    Investigated Drugs:
    • DUVELISIB
    • Bendamustine Hydrochloride
    • Gemcitabine Hydrochloride
    Belgium Czechia Denmark France Germany Italy +3

  • Study on the Effects of Darolutamide and Drug Combination for Patients with Metastatic Hormone-Naïve Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Triptorelin Acetate
    • Leuprorelin Acetate
    • Abiraterone
    Belgium Croatia Czechia Denmark France Ireland +4
Previous Page
1 … 5 6 7 8 9 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!